Johnson & Johnson to begin clinical trials on coronavirus vaccine candidate


Johnson & Johnson said Monday human screening of its experimental vaccine for the coronavirus would start by September and that it could be readily available for emergency use authorization in early 2021.

J&J also mentioned it experienced fully commited far more than $1 billion of expense alongside with U.S. company Biomedical Superior Analysis and Improvement Authority to co-fund vaccine exploration.

This is a breaking news story. Remember to examine back again for updates.



Source url